Related Experiment Video

Updated: Jan 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Opportunity knocking: shared tumor-associated antigen vaccines against global cancer pandemic

Olivera Finn1

  • 1Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA ojfinn@pitt.edu.

Journal for Immunotherapy of Cancer
|January 8, 2026
PubMed

Insights

Shared tumor-associated antigen (TAA) vaccines, once ineffective alone, show promise in combination immunotherapies. Repurposing these vaccines could offer inexpensive cancer prevention and treatment strategies globally.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Shared tumor-associated antigen (TAA) vaccines have a long history in cancer research aiming to improve patient outcomes and prevent cancer.
  • Previous attempts at TAA vaccine monotherapy were unsuccessful.
  • The tumor microenvironment can be modulated by checkpoint inhibitors and other agents, necessitating a re-evaluation of TAA vaccines.

Purpose of the Study:

  • To reassess the potential of shared TAA vaccines in combination immunotherapy.
  • To explore the repurposing of TAA vaccines for cancer prevention.
  • To highlight the unrecognized potential of TAA vaccines for current and future cancer control.

Main Methods:

  • Review of existing TAA vaccine technology and their historical performance.
  • Consideration of advancements in immunotherapy, particularly checkpoint inhibitors.
  • Evaluation of the feasibility of combining TAA vaccines with novel immunomodulatory agents.

Main Results:

  • TAA vaccines failed as monotherapy but may be effective in combination therapies.
  • Existing TAA vaccines are readily available in academic and pharmaceutical settings.
  • Repurposing TAA vaccines offers a strategy for broad cancer prevention.

Conclusions:

  • Shared TAA vaccines warrant reassessment in combination immunotherapy trials.
  • These vaccines could become broadly applicable, inexpensive, off-the-shelf options.
  • Repurposing TAA vaccines presents a significant opportunity for global cancer prevention and treatment.
Keywords:
Combination therapyImmune Checkpoint InhibitorImmunocompromisedImmunotherapyVaccine

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
946
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K